Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema – 1
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Diabetic retinopathy is the most common cause of vision loss in working-age Americans.
Cartwright: I suddenly realized when I was driving that I couldn’t see the road signs nor.
Balintfy: Sallie Cartwright went to her ophthalmologist and found out she needed to go to a specialist as soon as possible.
Cartwright: My right eye was worthless and my left eye was legally blind.
Balintfy: She participated in a clinical trial that found eye injections of a medication, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling in the eye. After the treatment, her vision is back. For details, visit www.nei.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.